INTRAVENOUS INJECTION OF IMMUNOGLOBULINS IN CHILDREN, SUFFERING SEPSIS
The efficacy of normal immunoglobulin of a man (NIM) injection in children, suffering sepsis and being in extremely severe state, was studied. Of 174 patients, who were treated for sepsis in 2005 - 2014 yrs., in 69 (39.6%)--NIM was applied, in 105 (60.3%)--did not apply. Positive changes of cellular immunity while immunotherapy application were noted. To estimate the immunotherapy efficacy it is mandatory to continue investigations with recruiting more quantity of patients.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2016 |
|---|---|
| Enthalten in: |
Klinichna khirurhiia - (2016), 1 vom: 15. Jan., Seite 58-60 |
| Sprache: |
Ukrainisch |
|---|
| Beteiligte Personen: |
Yachnyk, I M [VerfasserIn] |
|---|
| Themen: |
English Abstract |
|---|
| Anmerkungen: |
Date Completed 09.06.2016 Date Revised 18.10.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM260955043 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM260955043 | ||
| 003 | DE-627 | ||
| 005 | 20231224194515.0 | ||
| 007 | tu | ||
| 008 | 231224s2016 xx ||||| 00| ||ukr c | ||
| 028 | 5 | 2 | |a pubmed24n0869.xml |
| 035 | |a (DE-627)NLM260955043 | ||
| 035 | |a (NLM)27249931 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ukr | ||
| 100 | 1 | |a Yachnyk, I M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a INTRAVENOUS INJECTION OF IMMUNOGLOBULINS IN CHILDREN, SUFFERING SEPSIS |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 09.06.2016 | ||
| 500 | |a Date Revised 18.10.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The efficacy of normal immunoglobulin of a man (NIM) injection in children, suffering sepsis and being in extremely severe state, was studied. Of 174 patients, who were treated for sepsis in 2005 - 2014 yrs., in 69 (39.6%)--NIM was applied, in 105 (60.3%)--did not apply. Positive changes of cellular immunity while immunotherapy application were noted. To estimate the immunotherapy efficacy it is mandatory to continue investigations with recruiting more quantity of patients | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Immunoglobulins, Intravenous |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 700 | 1 | |a Karpenko, N P |e verfasserin |4 aut | |
| 700 | 1 | |a Antyukhin, S V |e verfasserin |4 aut | |
| 700 | 1 | |a Klubuk, I M |e verfasserin |4 aut | |
| 700 | 1 | |a Tryliska, T V |e verfasserin |4 aut | |
| 700 | 1 | |a Mehlnyk, V A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Klinichna khirurhiia |d 1993 |g (2016), 1 vom: 15. Jan., Seite 58-60 |w (DE-627)NLM085989835 |x 0023-2130 |7 nnns |
| 773 | 1 | 8 | |g year:2016 |g number:1 |g day:15 |g month:01 |g pages:58-60 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2016 |e 1 |b 15 |c 01 |h 58-60 | ||